Skip to main content

Table 2 Analysis of neighbor genes of the noncoding RNA transcripts (Group C versus Group A)

From: Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

Gene Symbol

Fold Change

P-value

Regulation

Same Strand Gene with Overlap

Up Stream Gene in 10,000 bp

Down Stream Gene in 10,000 bp

Complementary Strand Gene with Overlap

AP000487.4

1.57

0.03

up

   

PPFIA1

RP11-242O24.3

2.02

0.03

up

 

SRSF4

  

RP5-956O18.3

−2.76

<0.01

down

   

GALNT2

CITF22-24E5.1

1.76

0.01

up

   

PVALB

AC005009.2

−1.68

0.01

down

   

GRM3

RP4-613B23.3

2.03

<0.01

up

   

HHATL

RP11-49O14.3

−1.98

0.01

down

C9orf3

   

AP000320.6

1.8

0.03

up

   

KCNE2

RP4-631H13.2

−1.89

0.01

down

   

ZYG11A

RP5-1125A11.4

1.78

0.02

up

   

RALY

CTD-2023 N9.1

−1.64

0.03

down

   

ACTBL2

CTD-2116 N20.1

1.92

0.03

up

  

ADAMTS6

 

CTD-2201E9.4

−1.96

0.01

down

   

SEMA5A

CTC-345 K18.2

1.71

0.04

up

   

MYOZ3

CTC-348 L14.1

1.58

0.04

up

   

VCAN

RP11-654G14.1

−2.16

<0.01

down

SLC30A8

 

SLC30A8

 

RP11-279 L11.1

−1.53

0.02

down

CSMD1

   

KB-1083B1.1

−1.66

0.03

down

   

SNX31

RP11-173P15.3

−1.57

0.04

down

   

MLEC

RP11-1018 J8.2

1.56

0.01

up

RERG

RERG

  

RP13-820C6.2

−2.22

0.02

down

   

EP400

RP11-310I24.1

1.55

0.01

up

   

TMTC1

RP1-267 L14.3

2.13

0.04

up

   

NAA25

RP11-344B23.2

−1.67

0.03

down

   

PAX5

RP11-138H8.6

2.43

0.03

up

LARP6

LARP6

  

RP11-133 K1.5

1.71

0.04

up

   

PLCB2

RP11-538I12.3

−1.73

0.02

down

   

ADAMTS18

AC004449.6

−1.77

0.04

down

 

RNF126

POLRMT

 

RP11-327F22.5

−1.78

0.04

down

 

CYLD

  

RP11-30 L15.6

1.8

0.01

up

 

LYPLA1

  

RP13-638C3.4

1.6

0.01

up

   

FOXK2

RP11-227G15.2

1.73

0.03

up

 

RHBDL3

 

C17orf75

RP11-715F3.2

1.65

0.02

up

METTL4

METTL4

METTL4

 

RP11-640I15.1

−2.17

0.04

down

   

AC005324.3 TRIM16

RP11-973H7.3

2.84

0.03

up

CEP76

CEP76

 

PSMG2

CTB-189B5.3

1.58

0.02

up

   

FBXO27

RP11-91G21.1

−1.54

0.02

down

   

U2SURP

RP3-467 L1.6

−1.85

0.02

down

VAMP3

CAMTA1

PER3

 

LL09NC01-139C3.1

1.58

0.02

up

 

WDR5

  
  1. P <  0.05 was considered to be statistically significant
  2. Group A consisted of patients with IMH; Group C consisted of patients with PDR
  3. IMH Idiopathic macular hole, PDR Proliferative diabetic retinopathy